Life Science Company News

Reset
Results 221 - 240 out of 500 displayed.
«  1  2  3  4  5  6  7  8  9  10  11 12  13  14  15  16  17  18  19  20  21  22  23  24  25 »

Better Choice is Encouraged by the Potential DEA Reclassification of Marijuana

Read more ››
By: GlobeNewswire - 30 Apr 2024

Ultragenyx Issues 2023 Corporate Responsibility Report, Showcasing Commitment to Improving Equity and Access to Innovation in Rare Disease

Read more ››
By: GlobeNewswire - 30 Apr 2024
Related companies:  Ultragenyx Pharmaceutical Inc.

Galapagos’ shareholders adopt all resolutions proposed by the Board of Directors at the Annual and Extraordinary Shareholders Meetings 2024

Read more ››
By: GlobeNewswire - 30 Apr 2024
Related companies:  Galapagos NV

Lyra Therapeutics Reports First Quarter 2024 Financial Results and Provides Corporate Update

Read more ››
By: GlobeNewswire - 30 Apr 2024
Related companies:  Lyra Therapeutics, Inc.

Predictive Oncology Announces Significant Progress with FluGen In the Development of First-of-Its-Kind Intranasal Flu Vaccine

Read more ››
By: GlobeNewswire - 30 Apr 2024
Related companies:  Predictive Oncology Inc.

Stryker reports first quarter 2024 operating results

Read more ››
By: GlobeNewswire - 30 Apr 2024
Related companies:  Stryker Corporation

Myriad Genetics to Release First Quarter 2024 Financial Results on May 7, 2024

Read more ››
By: GlobeNewswire - 30 Apr 2024
Related companies:  Myriad Genetics, Inc.

Merit Medical Reports Results for First Quarter Ended March 31, 2024

Read more ››
By: GlobeNewswire - 30 Apr 2024
Related companies:  Merit Medical Systems, Inc.

Exagen to Announce First Quarter 2024 Results on May 13, 2024

Read more ››
By: GlobeNewswire - 30 Apr 2024
Related companies:  Exagen Inc.

Silk Road Medical Reports First Quarter 2024 Financial Results

Read more ››
By: GlobeNewswire - 30 Apr 2024
Related companies:  Silk Road Medical,Inc.

CVRx Reports First Quarter 2024 Financial and Operating Results

Read more ››
By: GlobeNewswire - 30 Apr 2024
Related companies:  CVRx, Inc.

SCYNEXIS Presented Preclinical Data on Second Generation Fungerp SCY-247 at the Congress of the European Society of Clinical Microbiology and Infectious Diseases (ESCMID Global, Formerly ECCMID)

Read more ››
By: GlobeNewswire - 30 Apr 2024
Related companies:  Scynexis Inc

Aligos Therapeutics to Announce 1st Quarter 2024 Financial Results on May 7, 2024

Read more ››
By: GlobeNewswire - 30 Apr 2024
Related companies:  Aligos Therapeutics, Inc.

Inari Medical Reports First Quarter 2024 Financial Results

Read more ››
By: GlobeNewswire - 30 Apr 2024
Related companies:  Inari Medical, Inc.

Clover Health Announces Inducement Grant under Nasdaq Listing Rule 5635(c)(4)

Read more ››
By: GlobeNewswire - 30 Apr 2024

BioRestorative Therapies to Report First Quarter 2024 Financial Results and Host Conference Call on May 14, 2024

Read more ››
By: GlobeNewswire - 30 Apr 2024
Related companies:  BioRestorative Therapies, Inc.

CooperCompanies Announces Release Date for Second Quarter 2024

Read more ››
By: GlobeNewswire - 30 Apr 2024
Related companies:  The Cooper Companies, Inc.

Clearmind Applies to Cease Being a Reporting Issuer in Canada

Read more ››
By: GlobeNewswire - 30 Apr 2024
Related companies:  Clearmind Medicine Inc.

Integra LifeSciences to Spotlight CereLink® Intracranial Pressure (ICP) Monitoring System at the American Association of Neurological Surgeons (AANS) Annual Scientific Meeting

Read more ››
By: GlobeNewswire - 30 Apr 2024
Related companies:  Integra LifeSciences

Dyadic to Report First Quarter 2024 Financial Results on Tuesday, May 14, 2024

Read more ››
By: GlobeNewswire - 30 Apr 2024
Related companies:  Dyadic International, Inc.
Results 221 - 240 out of 500 displayed.
«  1  2  3  4  5  6  7  8  9  10  11 12  13  14  15  16  17  18  19  20  21  22  23  24  25 »

Enhance your business development with Biotechgate
Try for free »